H
Loading...
Loading...
Knee biologics are the highest-volume joint service line for most orthopedic and sports clinics. Product choice (PRP vs. 361 tissue vs. HA) should follow imaging, alignment, and payer — not a single “knee shot” SKU.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18.
Biologic injections for knee pain and degeneration. PRP, tissue allografts, and other options for knee joint treatment.
Knees are where most practices start because volume is there. Start with one injectate, one documentation template, and a centrifuge owner. Expanding to three SKUs in week one is how lots go missing.
Varus deformity and bone-on-bone medial OA limit what an injection can do. Say that before the draw.
Knee injectate volume is a device and joint-size decision. Underfilling is a technique error, not a brand failure.
Quad loading and weight management still move outcomes more than a second brand of PRP.
Clinically possible; billing and consent should list both.
Often complementary. Not sold as a biologic.
Standard intra-articular risk counseling applies.
Some protocols combine; code both honestly.
Contact us today to learn how Hawk Medical can support your practice.
We're not just a distributor - we're healthcare providers who understand your challenges
We own and operate medical clinics, so we understand your real-world challenges
All products meet strict regulatory requirements including HCT/P 361 compliance
Personal account management and ongoing training for your entire team
10+ years of experience helping practices implement successful programs
Learn more about related treatments, solutions, and resources
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.